 |
Contact Us Sitemap |
 |
|
 |
|
Products In DevelopmentZADAXIN®ZADAXIN Melanoma ZADAXIN HCV SCV-07 RP101 DC Bead™ |
 |
We are planning to launch and commercialize DC Bead™ in China for the treatment of liver cancer in the second half of 2008. DC Bead is an embolic agent with the capability of also targeting a chemotherapeutic agent directly to the tumor site. Liver cancer is one of the most prevalent and deadly forms of cancer in China , accounting for over 300,000 deaths each year.
In June 2006, we acquired the exclusive Chinese marketing rights to DC Bead from Biocompatibles International plc. DC Bead is comprised of microscopic beads, which when administered by catheter into a blood vessel, block the supply of nutrients and blood to a tumor. While the blockage of the blood vessel itself can have an anti-tumor effect, chemotherapeutic agents can be added to the beads for a more targeted anti-tumor effect. This controlled delivery of an anti-tumor drug concentrates the toxic effect of the drug directly on the tumor and minimizes side effects throughout the rest of the body. DC Bead is designed to deliver doxorubicin and potentially can deliver other chemotherapy drugs as well.Site design by Formative